Paper Details

  1. Home
  2. Paper Details

Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis.

Author: AbelsonMark B, GomesPaul J, PasquineTerri A, RobertsonStella M, TurnerF Darell, VogelsonCullen T, WellsDavid T

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Olopatadine hydrochloride ophthalmic solution is effective and safe for treating seasonal allergic conjunctivitis or rhinoconjunctivitis.
Paper Details　
Original Abstract of the Article :
A new formulation of olopatadine hydrochloride ophthalmic solution (olopatadine 0.2%) was evaluated in two separate, randomized, placebo-controlled, double-masked, hybrid environmental studies intended to determine efficacy and safety in subjects with histories of seasonal allergic conjunctivitis or...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1185/030079905X43622

データ提供：米国国立医学図書館（NLM）

Olopatadine Ophthalmic Solution: A Cool Oasis in the Desert of Allergies

Allergic conjunctivitis and rhinoconjunctivitis can be a real nuisance, like a pesky sandstorm blowing in your eyes. This study explores the effectiveness of a new formulation of olopatadine hydrochloride ophthalmic solution in treating these conditions.

A New Solution for Allergic Eyes: A Camel's Perspective

This research evaluated the efficacy of a new formulation of olopatadine ophthalmic solution in subjects with allergic conjunctivitis or rhinoconjunctivitis. The study showed that this solution demonstrated [efficacy] in relieving nasal symptoms in subjects with allergic conjunctivitis or rhinoconjunctivitis.

Eyesight Relief in the Desert: A Camel's Recommendation

This study suggests that olopatadine ophthalmic solution may offer a valuable alternative for managing allergic eye conditions. It's a reminder that, just like the desert offers diverse forms of life, there are many approaches to managing allergies. Consulting your physician to determine the best treatment for you is essential.

Dr. Camel's Conclusion

The study emphasizes the importance of exploring new treatment options for allergic eye diseases. It's a reminder that, in the vast desert of allergies, finding effective and safe treatments is a continuous quest, much like a camel's search for an oasis.

Date :
  1. Date Completed 2005-08-02
  2. Date Revised 2022-03-16
Further Info :

Pubmed ID

15969867

DOI: Digital Object Identifier

10.1185/030079905X43622

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.